Skip to content

Agilent Technologies A Net Investment in Lease

Net Investment in Lease at other companies

Revvity logo
RevvityRVTY
Danaher logo
DanaherDHR
WAT
Waters CorporationWAT
908 Devices logo
908 DevicesMASS
Twist Bioscience Corporation logo
Twist Bioscience CorporationTWST
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO

Other financials

Income statement

See full
Revenue$1.8B+10.0%
Gross profit$990.0M+14.3%
Operating income$399.0M+33.0%
Net income$339.0M+57.7%
EPS (diluted)$1.20+60.0%

Balance sheet

See full
Cash & equivalents$1.8B+21.5%
Total debt$3.5B-3.9%
Total equity$7.1B+16.1%
Total assets$13.1B+7.5%

Cash flow

See full
Operating cash flow$277.0M+25.3%
CapEx$76.0M-33.3%
Free cash flow$201.0M+87.9%

Valuation

See full
Market cap$37.52B+8.8%
Enterprise value$39.25B+7.0%
P/E26.5×-3.0×
P/S5.2×0.0×

Profitability

See full
Gross margin52.7%-0.6pp
Operating margin21.5%+0.1pp
Net margin19.6%+2.0pp
FCF margin15%-2.9pp

Returns & leverage

See full
Return on equity21.3%+2.4pp
Debt / equity0.5×-0.1×
Current ratio2.1×0.0×

Where this comes from

Reported directly by Agilent Technologies in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Agilent Technologies’s 10-Q, filed June 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Agilent Technologies's net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Agilent Technologies's net investment in lease?
Agilent Technologies (A) reported net investment in lease of $181M in Q1 2026.
How has Agilent Technologies's net investment in lease changed year-over-year?
Agilent Technologies's net investment in lease decreased by 0.5% year-over-year, from $182M to $181M.
What is the long-term trend for Agilent Technologies's net investment in lease?
Over 5 years (2020 to 2025), Agilent Technologies's net investment in lease has grown at a 33.0% compound annual growth rate (CAGR), from $44M to $183M.